Retatrutide Dose in Units: mg to Units and Syringe Math
Why a retatrutide dose in units depends on the vial concentration, how mg, mL, and insulin syringe units relate, and why retatrutide is still an investigational drug.
Last reviewed
The Vital angle
When you add a vial in Vital, you enter the mg in the vial and the water added, and the app shows the concentration, the U-100 units and mL for the amount your prescriber gave you, and the doses per vial. It warns when a draw is more than a 1 mL syringe holds. Each log keeps the unit you used, such as mg, mcg, units, or mL, so your history stays clear when a vial changes.
Why "retatrutide dose in units" has no single answer
People search for a retatrutide dose in units because many vials are drawn with an insulin syringe, and that syringe is marked in units, not milligrams. The problem is that a "unit" on a syringe is a volume mark. It does not tell you how much drug is in that volume. The same number of units can hold very different amounts of drug, depending on how the vial was mixed.
Before any math, one fact matters most: retatrutide is not an approved drug. It is an investigational medicine from Eli Lilly and Company that is still in clinical trials, including the phase 3 TRIUMPH program on ClinicalTrials.gov. There is no FDA-approved label, no approved dose, and no approved vial. Products sold online as retatrutide, often labeled "for research use only," are not approved drugs. The FDA says retatrutide cannot be used in compounding under federal law, and it has sent warning letters to companies that market it.
This guide explains the arithmetic so you can understand a label and ask better questions. It does not give a dose. Only a prescriber or a clinical trial team can tell you what to take.
Three different measures: mg, mL, and units
Most dosing confusion comes from three measures that sound alike but mean different things.
- Milligrams (mg) measure the amount of drug. Clinical trials report retatrutide doses in mg.
- Milliliters (mL) measure the volume of liquid.
- Units on a U-100 insulin syringe are a volume scale: 100 units equal 1 mL, so 1 unit equals 0.01 mL.
The link between mg and mL is the concentration, written as mg per mL. You need the concentration to turn a mg amount into a volume, and then the volume into units. Without it, a number of units means nothing about the dose.
The FDA has reported hospital visits linked to this exact confusion with compounded semaglutide. Patients mixed up mg, mL, and units, and some drew 50 units on a U-100 syringe when they meant 5. The same risk applies to any drug drawn from a vial, including retatrutide.
How the mg to units math works
The arithmetic has three steps. The numbers below are hypothetical round numbers chosen only to show the math. They are not doses and not a recommendation.
- Find the concentration. Divide the drug in the vial by the liquid added. Math example: 10 mg in a vial with 2 mL of liquid gives 10 ÷ 2 = 5 mg per mL.
- Find the volume. Divide the amount by the concentration. Math example: an amount of 1 mg at 5 mg per mL is 1 ÷ 5 = 0.2 mL.
- Convert to units. Multiply the mL by 100 for a U-100 syringe. Math example: 0.2 mL × 100 = 20 units.
A quick check: at 5 mg per mL, each U-100 unit holds 0.05 mg. Confirm every draw with your prescriber or pharmacist before you inject. The math is easy to get wrong by a factor of ten, and a factor-of-ten error is exactly what the FDA reports describe.
For the full mixing steps, see how to reconstitute peptides with bac water.
Why a "10 mg vial" can mean different units
A label such as "retatrutide 10 mg" tells you the total drug in the vial. It does not tell you the concentration, because that depends on how much liquid goes in. Change the liquid and every unit count changes too.
Math example with the same hypothetical 10 mg vial:
| Liquid added | Concentration | Units for a 1 mg math example |
|---|---|---|
| 1 mL | 10 mg/mL | 10 units |
| 2 mL | 5 mg/mL | 20 units |
| 3 mL | about 3.33 mg/mL | about 30 units |
The amount of drug in each row is the same. Only the volume changes. This is why a unit number copied from a forum, a friend, or an old vial can be wrong for your vial. Ask your prescriber or pharmacist to write the amount in mg and the volume in mL or units for your exact vial, and ask again each time the vial or the mixing volume changes.
Why retatrutide logs get confused
Dose records go wrong in a few common ways:
- Units logged without the concentration. "20 units" in a log is only useful if you also know the mg per mL for that vial.
- A new vial, a new strength. A refill with a different total mg, or a different volume of liquid, changes the units for the same mg amount.
- Wrong syringe scale. Most peptide math assumes a U-100 syringe. A U-40 syringe uses a different scale. See U-40 vs U-100 syringes.
- mcg and mg mix-ups. 1 mg equals 1,000 mcg. A missing decimal is a thousand-fold error.
- Rounding on small syringes. Many 1 mL syringes mark only every 2 units, so small volumes are hard to read.
A clear habit is to log the mg amount, the volume drawn, the vial strength, and the date the vial was mixed, every time. This also helps at appointments. See keeping a dose log for doctor visits.
What investigational status means for you
An investigational drug has not finished the review the FDA uses to decide whether a drug is safe and effective for a use. For retatrutide, that means:
- No approved product exists outside clinical trials.
- Trial results do not tell you how a product bought elsewhere was made, what it contains, or how pure it is.
- Products sold "for research purposes" or "not for human consumption" are not made for patients, and the FDA warns against them.
- The vial label may be wrong. A unit calculation is only as good as the mg number on the label.
If you are thinking about retatrutide, the safest path is to talk to a licensed clinician, and ask about approved options or about joining a clinical trial. For more on checking a seller, see peptide catalog source checks.
Warning signs that need care
Drugs in this class act on the gut and blood sugar. Get medical help if you have any of these after a dose:
- Severe stomach pain that does not go away, with or without vomiting. This can be a sign of pancreatitis.
- Vomiting or diarrhea that stops you from keeping fluids down, or signs of dehydration such as dizziness or very little urine.
- Pain in the upper right belly, fever, or yellow skin or eyes.
- Shakiness, sweating, confusion, or fainting, especially if you also take insulin or a sulfonylurea.
- Swelling of the face or throat, or trouble breathing.
If you think you drew or injected too much, call your prescriber or Poison Help at 1-800-222-1222. If symptoms are severe, call emergency services or go to an emergency room. For milder effects after a change, see side effects after a dose increase.
Questions to ask your prescriber or pharmacist
Bring these questions to your next visit:
- What is the amount in mg, and what is the volume in mL or units for my vial?
- What concentration is my vial in mg per mL?
- Which syringe size and scale should I use?
- What changes if my next vial has a different strength?
- Which symptoms mean I need to call you right away?
Write the answers down and keep them with the vial.
Things to watch
Practical flags drawn from prescribing information and clinical guidance. Vital surfaces these in the dose log to help you spot them early.
Unapproved retatrutide products
Retatrutide is an investigational drug in clinical trials. No FDA-approved product or dose exists, and the FDA says it cannot be used in compounding under federal law.
Units copied without a concentration
A syringe unit is a volume mark. The same number of units holds a different amount of drug when the vial strength or the mixing volume changes.
Mixing up mg, mL, and units
The FDA reported hospital visits from this confusion with compounded semaglutide, including patients who drew 50 units on a U-100 syringe instead of 5.
mcg and mg errors
1 mg equals 1,000 mcg. A misplaced decimal or a wrong unit label can cause a very large dosing error.
Using a U-40 syringe with U-100 math
U-40 and U-100 syringes use different scales. A unit count worked out for U-100 does not match the marks on a U-40 barrel.
Products labeled for research use
The FDA warns against drugs sold "for research purposes" or "not for human consumption." These are not made for patients.
Frequently asked questions
There is no fixed number. Units on an insulin syringe measure volume, so the units for any mg amount depend on the vial concentration. Retatrutide is also investigational and has no approved dose. Ask your prescriber or trial team.
Divide the mg in the vial by the mL of liquid to get mg per mL. Divide the mg amount by that number to get mL, then multiply by 100 for a U-100 syringe. Confirm every draw with your prescriber or pharmacist.
There is no approved answer, because retatrutide has no approved vial or label. The volume of liquid changes the concentration and every unit count. Ask the prescriber or pharmacist who gave you the vial.
No. Retatrutide is an investigational drug from Eli Lilly and Company that is still in clinical trials. Products sold online as retatrutide are not approved drugs.
A new vial can have a different total mg or be mixed with a different volume of liquid. Both change the concentration, so the same mg amount needs a different number of units.
Call your prescriber or Poison Help at 1-800-222-1222. Get emergency care for severe stomach pain, vomiting you cannot stop, fainting, or trouble breathing.
Sources
- A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight (TRIUMPH-1) · ClinicalTrials.gov, U.S. National Library of Medicine
- Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial · The New England Journal of Medicine, via PubMed
- What retatrutide clinical trials are being conducted in people with obesity or overweight? · Eli Lilly and Company Medical Information
- FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products · U.S. Food and Drug Administration
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · U.S. Food and Drug Administration
This page summarizes publicly available information from the sources listed above and is for educational use only. It is not medical advice. Consult a qualified healthcare professional for personal dosing guidance.
Track every shot, every change
Vital logs every GLP-1 injection and peptide dose, then surfaces patterns your scale can't show. Free on iOS and Android.
More from the Library
Compounded Tirzepatide Dosage Chart in Units: mg to Units by Vial Strength
A compounded tirzepatide dosage chart in units: the label dose steps from 2.5 to 15 mg, converted to mL and U-100 syringe units at common compounded vial concentrations, with the math and the errors to avoid.
Peptide Injection Schedule: How to Set Up Non-Weekly Reminders That Stay Correct
How to turn a peptide injection schedule from your prescriber into reminders: every 5 days, every other day, 5 on 2 off, and twice weekly, with a printable calendar template and the label rules for weekly drugs.
GLP-1 Dosing Schedules
How GLP-1 titration actually works. Why doses step up slowly, how long to plateau at each step, and what to do with missed doses.
How Many Doses in a Vial: The Math, Dead Space, and Discard Dates
How many doses in a vial you really get: the doses-per-vial formula, how syringe dead space and leftover liquid cut the count, why the 28-day or beyond-use date can end a vial first, and how to plan refills.